Aardvark Therapeutics, Inc. Common Stock Net Asset Momentum
Aardvark Therapeutics, Inc. Common Stock net asset momentum. Aardvark Therapeutics, Inc. Common Stock (AARD) recorded a net asset momentum of -57.0% as of December 2024, with net assets of $-54.64 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Aardvark Therapeutics, Inc. Common Stock cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Aardvark Therapeutics, Inc. Common Stock (2022–2024)
Net asset momentum of Aardvark Therapeutics, Inc. Common Stock from 2022 to 2024. This chart tracks Aardvark Therapeutics, Inc. Common Stock's year-over-year net asset growth across 3 annual reporting periods from 2022 to 2024. The most recent momentum reading is -57.0%, with net assets of $-54.64 Million USD as of December 2024. See Aardvark Therapeutics, Inc. Common Stock net assets for net asset value and shareholders' equity analysis.
Aardvark Therapeutics, Inc. Common Stock Net Asset Momentum by Year (2022–2024)
Aardvark Therapeutics, Inc. Common Stock net asset momentum by year from 2022 to 2024. The table below shows the complete annual net asset history for Aardvark Therapeutics, Inc. Common Stock from 2022 to 2024, covering 3 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Aardvark Therapeutics, Inc. Common Stock (AARD) total market value.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $-54.64 Million | $77.51 Million | $132.15 Million | ▼ -57.0% |
| 2023 | $-34.80 Million | $10.54 Million | $45.34 Million | ▼ -24.6% |
| 2022 | $-27.92 Million | $16.76 Million | $44.68 Million | — |